- Ebola outbreak in Western Africa 2014: what is going on with Ebola virus?
-
Na W, Park N, Yeom M, Song D
- KMID: 2049104
- Clin Exp Vaccine Res.
- 2015 Jan;4(1):17-22.
- doi: 10.7774/cevr.2015.4.1.17
The 2014 outbreak of Ebola virus disease (EVD) in West Africa, caused by Ebola virus (Zaire Ebola virus species), is the largest outbreak of EVD in history. It cause hemorrhagic... -
- CITED
-
- Close
- SHARE
-
- Close
- What do we really fear? The epidemiological characteristics of Ebola and our preparedness
-
Ki M
- KMID: 2380558
- Epidemiol Health.
- 2014;36:e2014014.
- doi: 10.4178/epih/e2014014
Ebola virus disease (hereafter Ebola) has a high fatality rate; currently lacks a treatment or vaccine with proven safety and efficacy, and thus many people fear this infection. As of... -
- CITED
-
- Close
- SHARE
-
- Close
- Preparedness for Prevention of Ebola Virus Disease
-
Hwang ES
- KMID: 1794593
- J Korean Med Sci.
- 2014 Sep;29(9):1185-1185.
- doi: 10.3346/jkms.2014.29.9.1185
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Progress of vaccine and drug development for Ebola preparedness
-
Choi WY, Hong KJ, Hong JE, Lee WJ
- KMID: 2049103
- Clin Exp Vaccine Res.
- 2015 Jan;4(1):11-16.
- doi: 10.7774/cevr.2015.4.1.11
Since the first case of Ebola virus disease (EVD) in Guinea was reported in March 2014 by World Health Organization (WHO), the outbreak has continued through the year and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production
-
Lee SH, Han BS, Choe J, Sin JI
- KMID: 2391574
- Clin Exp Vaccine Res.
- 2017 Jul;6(2):135-145.
- doi: 10.7774/cevr.2017.6.2.135
PURPOSE: The goal of this study was to investigate the utility of DNA vaccines encoding Ebola virus glycoprotein (GP) as a vaccine type for the production of GP-specific hybridomas and... -
- CITED
-
- Close
- SHARE
-
- Close
- Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
-
Han BS, Jang HY, Racine T, Qiu X, Sin JI
- KMID: 2418090
- Clin Exp Vaccine Res.
- 2018 Jul;7(2):119-128.
- doi: 10.7774/cevr.2018.7.2.119
PURPOSE: The goal of this study was to purify and characterize Ebola virus glycoprotein (GP)-specific IgG antibodies from hybridoma clones. MATERIALS AND METHODS: For hybridoma production, mice were injected by intramuscular-electroporation... -
- CITED
-
- Close
- SHARE
-
- Close
- One Health Perspectives on Emerging Public Health Threats
-
Ryu S, Kim BI, Lim JS, Tan CS, Chun BC
- KMID: 2398229
- J Prev Med Public Health.
- 2017 Nov;50(6):411-414.
- doi: 10.3961/jpmph.17.097
Antimicrobial resistance and emerging infectious diseases, including avian influenza, Ebola virus disease, and Zika virus disease have significantly affected humankind in recent years. In the premodern era, no distinction was... -
- CITED
-
- Close
- SHARE
-
- Close
